William Blair & Company
PPH icon

William Blair & Company’s VanEck Pharmaceutical ETF PPH Stock Holding History

William Blair & Company’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
12,498
+156
+1% +$16.1K ﹤0.01% 876
2026
Q1 		$1.28M Hold
12,342
– – ﹤0.01% 863
2025
Q4 		$1.27M Buy
12,342
+28
+0.2% +$2.72K ﹤0.01% 872
2025
Q3 		$1.11M Buy
12,314
+19
+0.2% +$1.66K ﹤0.01% 889
2025
Q2 		$1.08M Buy
12,295
+3,140
+34% +$272K ﹤0.01% 877
2025
Q1 		$834K Sell
9,155
-76
-0.8% -$6.84K ﹤0.01% 937
2024
Q4 		$796K Buy
9,231
+106
+1% +$9.59K ﹤0.01% 969
2024
Q3 		$867K Buy
9,125
+2,184
+31% +$207K ﹤0.01% 944
2024
Q2 		$635K Buy
6,941
+924
+15% +$82.5K ﹤0.01% 1027
2024
Q1 		$546K Buy
6,017
+2,894
+93% +$253K ﹤0.01% 1062
2023
Q4 		$254K Sell
3,123
-465
-13% -$36.5K ﹤0.01% 1316
2023
Q3 		$287K Buy
3,588
+2,706
+307% +$218K ﹤0.01% 1254
2023
Q2 		$69.5K Hold
882
– – ﹤0.01% 1554
2023
Q1 		$68.5K Hold
882
– – ﹤0.01% 1547
2022
Q4 		$68.6K Buy
882
+682
+341% +$50.3K ﹤0.01% 1534
2022
Q3 		$13K Hold
200
– – ﹤0.01% 1726
2022
Q2 		$15K Hold
200
– – ﹤0.01% 1750
2022
Q1 		$16K Hold
200
– – ﹤0.01% 1809
2021
Q4 		$15K Buy
+200
New +$14.9K ﹤0.01% 1873
2020
Q2 		– Sell
-90
Closed -$5K – 1729
2020
Q1 		$5K Hold
90
– – ﹤0.01% 1591
2019
Q4 		$6K Hold
90
– – ﹤0.01% 1659
2019
Q3 		$5K Sell
90
-45
-33% -$2.58K ﹤0.01% 1640
2019
Q2 		$8K Sell
135
-89
-40% -$5.15K ﹤0.01% 1657
2019
Q1 		$14K Buy
224
+179
+398% +$10.6K ﹤0.01% 1603
2018
Q4 		$2K Sell
45
-150
-77% -$9.09K ﹤0.01% 1637
2018
Q3 		$13K Hold
195
– – ﹤0.01% 1556
2018
Q2 		$12K Hold
195
– – ﹤0.01% 1523
2018
Q1 		$11K Buy
+195
New +$11.7K ﹤0.01% 1452

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

William Blair & Company's PPH Position: Q2 2026 in Review

William Blair & Company increased its VanEck Pharmaceutical ETF (PPH) stake by 1.3% in Q2 2026, buying an estimated $16.1K and bringing the position to 12,498 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #876.

William Blair & Company first reported a position in PPH in Q1 2018 and has held it in 28 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • William Blair & Company held 12,498 shares of VanEck Pharmaceutical ETF worth $1.37M as of Q2 2026.
  • William Blair & Company bought 156 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $16.1K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #876 holding.
  • William Blair & Company first reported a position in VanEck Pharmaceutical ETF in Q1 2018 and has held it in 28 quarters since.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.